Sambrosa
- Product NDC
- 60665-003
- 11-digit product format
- 606650003
- Labeler code
- 60665
- Product ID
- 60665-003_47ceb0bf-5593-9021-e063-6294a90a4ce1
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- DOXYLAMINE SUCCINATE
- Dosage form
- SYRUP
- Route
- ORAL
- Labeler
- Sambrosa Care, Inc.
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2020-01-10
- Substance
- DOXYLAMINE SUCCINATE
- Active strength
- 9.78 mg/3mL
- Pharmacologic classes
- Antihistamine [EPC], Histamine Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 60665-003-04 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 60665-003-02 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 60665-003-03 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 60665-003-01 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 60665-003-04 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 60665-003-02 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 60665-003-03 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 60665-003-01 | f5e01cc5f278… | a2eaf40c39c3… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Sambrosa
- Brand name suffix
- Night
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DOXYLAMINE SUCCINATE | 9.78 mg/3mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| V9BI9B5YI2 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2390292 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| acdc8740-6231-d1e8-e053-2995a90a3b8d | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 59361619-24d9-b610-eca6-5a7f25ed5e03 | Product name | 5 | 20240909 |
| f4368033-af8c-41bf-a84b-ff77392b8522 | Product name | 1 | 20161229 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 60665-003-01 | 2026-01-13 | acdc8740-6231-d1e8-e053-2995a90a3b8d |
| 60665-003-02 | 2026-01-13 | acdc8740-6231-d1e8-e053-2995a90a3b8d |
| 60665-003-03 | 2026-01-13 | acdc8740-6231-d1e8-e053-2995a90a3b8d |
| 60665-003-04 | 2026-01-13 | acdc8740-6231-d1e8-e053-2995a90a3b8d |
| 60665-003-01 | 2025-07-29 | acdc8740-6231-d1e8-e053-2995a90a3b8d |
| 60665-003-02 | 2025-07-29 | acdc8740-6231-d1e8-e053-2995a90a3b8d |
| 60665-003-03 | 2025-07-29 | acdc8740-6231-d1e8-e053-2995a90a3b8d |
| 60665-003-04 | 2025-07-29 | acdc8740-6231-d1e8-e053-2995a90a3b8d |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60665-003-01 | SambrosaNight | 100 mL in 1 BOTTLE | SYRUP | 100 | 8 | |
| 60665-003-01 | SambrosaNight | 1 in 1 CARTON | SYRUP | 1 | 8 | |
| 60665-003-02 | SambrosaNight | 1 in 1 CARTON | SYRUP | 1 | 8 | |
| 60665-003-02 | SambrosaNight | 30 mL in 1 BOTTLE | SYRUP | 30 | 8 | |
| 60665-003-03 | SambrosaNight | 300 mL in 1 BOTTLE | SYRUP | 300 | 8 | |
| 60665-003-03 | SambrosaNight | 1 in 1 CARTON | SYRUP | 1 | 8 | |
| 60665-003-04 | SambrosaNight | 3 mL in 1 POUCH | SYRUP | 3 | 8 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Alka-Seltzer Plus Severe Cold Night PowerFast Fizz | ASPIRIN, DOXYLAMINE SUCCINATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE BITARTRATE | Bayer HealthCare LLC. | c1fae6c7-bbac-1320-e053-2a95a90aac5a | 2026-01-08 | Warnings | M012 |
| Alka-Seltzer Plus Night Severe Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, AND PHENYLEPHRINE HYDROCHLORIDE | Bayer HealthCare LLC. | f4c60ca1-ba59-4a92-84a5-6ba65faa56ab | 2026-01-08 | Warnings | M012 |
| Alka-Seltzer Plus Day Severe Cold Plus Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Bayer HealthCare LLC. | cec51eab-cce3-4965-a14e-a46d953050c4 | 2026-01-08 | Warnings | M012 |
| VanaCof 2 | CHLOPHEDIANOL HCL, DEXCHLORPHENIRAMINE MALEATE | GM Pharmaceuticals, INC | 0c7c6756-abb2-c10c-e063-6394a90a9863 | 2026-01-08 | Warnings | M012 |
| VANACOF XP Cough / Chest Congestion | DEXTROMETHORPHAN HBR, GUAIFENESIN | GM Pharmaceuticals, INC | 0b3a8cc1-a49f-e1e5-e063-6394a90a1c06 | 2026-01-08 | Warnings | M012 |
| Diphenhydramine HCl | DIPHENHYDRAMINE HCL | INVAHEALTH INC | e4e4004f-77e3-569d-e053-2a95a90a73fe | 2026-01-08 | Warnings | M012 |
| Robitussin Maximum Strength Cough Plus Chest Congestion DM | DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN | Haleon US Holdings LLC | 868ac65a-63e2-46ac-b87d-66b289086756 | 2026-01-08 | Warnings | M012 |
| Theraflu Flu Relief Max Strength Daytime | ACETAMINOPHEN, DEXTROMETHORPHAN HBR | Haleon US Holdings LLC | 0324195f-506d-4747-990e-ad44e2a117d9 | 2026-01-07 | Warnings | M012 |
| Sambrosa Night | DOXYLAMINE SUCCINATE | Sambrosa Care, Inc. | acdc8740-6231-d1e8-e053-2995a90a3b8d | 2026-01-07 | Warnings | M012 60665-003 |
| VAPOREX | CAMPHOR (SYNTHETIC), EUCALYPTUS OIL, AND MENTHOL | DLC Laboratories, Inc. | 971943b1-4199-4f75-9d2d-61242d346b5f | 2026-01-07 | Warnings | M012 |
| BACTIMICINA COUGH AND COLD | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | DLC Laboratories, Inc. | 2e612c62-9bbb-45f2-a253-aa2bfaeaac70 | 2026-01-07 | Warnings | M012 |
| Earths Care Chest Rub | CAMPHOR, EUCALYPTUS OI, MENTHOL | DLC Laboratories, Inc | 2424f5d5-1772-96f1-e063-6294a90a89ee | 2026-01-07 | Warnings | M012 |
| Bactimicina Vapor Rub | VAPOR RUB | DLC Laboratories, Inc. | 176b617a-faf6-7893-e063-6294a90a046b | 2026-01-07 | Warnings | M012 |
| Sinus Pressure and Pain | ACETAMINOPHEN, PHENYLEPHRINE HCL | Family Dollar Services Inc | 0d3e4ceb-5059-4aac-8aa2-bf714ca9deb2 | 2026-01-07 | Warnings | M012 |
| Tussin Multi Symptom Cold CF | DEXTROMETHORPHAN HBR GUAIFENESIN PHENYLEPHRINE HCL | QUALITY CHOICE (Chain Drug Marketing Association) | b225e897-5728-4519-b727-c0f361c75976 | 2026-01-07 | Warnings | M012 |
| Severe Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | Walgreen Company | 80b218f7-66bb-4e15-a0dc-ec9b6af1b056 | 2026-01-07 | Warnings | M012 |
| tussin cough and chest congestion | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | Rite Aid Corporation | 13618054-d0c5-4190-b626-e7e91b855738 | 2026-01-06 | Warnings | M012 |
| Berkley and Jensen Tussin DM Max | DEXTROMETHORPHAN HBR, GUAIFENESIN | BJWC | c15b97a8-968f-4d38-905e-863e9fd16ce6 | 2026-01-06 | Warnings | M012 |
| Complete Allergy Medicine | DIPHENHYDRAMINE HCL | Salado Sales, Inc. | c0f5c8ca-b187-40bf-9245-6a29f1c32c97 | 2026-01-06 | Warnings | M012 |
| Allergy Multi-Symptom | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL | Cardinal Health 110, LLC. DBA Leader | c5776b1e-9f72-4a6a-9961-8ac8e05b3249 | 2026-01-06 | Warnings | M012 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2390292 | doxylamine succinate 9.78 MG in 3 mL Oral Solution | PSN | acdc8740-6231-d1e8-e053-2995a90a3b8d | 8 |
| 2390292 | doxylamine succinate 3.26 MG/ML Oral Solution | SCD | acdc8740-6231-d1e8-e053-2995a90a3b8d | 8 |
| 2390292 | doxylamine succinate 9.78 MG per 3 mL Oral Solution | SY | acdc8740-6231-d1e8-e053-2995a90a3b8d | 8 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 60665-003-01 | 60665000301 | 1 BOTTLE in 1 CARTON (60665-003-01) / 100 mL in 1 BOTTLE | 1 bottle | 2020-01-10 | 0000-00-00 | No | No | Current |
| 60665-003-02 | 60665000302 | 1 BOTTLE in 1 CARTON (60665-003-02) / 30 mL in 1 BOTTLE | 1 bottle | 2020-12-01 | 0000-00-00 | No | No | Current |
| 60665-003-03 | 60665000303 | 1 BOTTLE in 1 CARTON (60665-003-03) / 300 mL in 1 BOTTLE | 1 bottle | 2020-01-10 | 0000-00-00 | No | No | Current |
| 60665-003-04 | 60665000304 | 3 mL in 1 POUCH (60665-003-04) | 3 ml | 2021-10-26 | 0000-00-00 | No | No | Current |